ASA分级≥3级患者同日出院全关节置换术与90天不良事件风险的相关性
本研究基于Kaiser Permanente全关节置换登记系统,纳入2017至2018年ASA分级≥3级、因骨关节炎行初次择期全髋或全膝关节置换的患者,比较同日出院与住院患者90天不良事件风险。采用倾向评分加权Cox回归及非劣效检验(界值1.10),结果显示同日出院患者急诊就诊、非计划再入院和并发症风险不高于住院患者,髋关节置换死亡风险非劣效性证据不足,膝关节置换死亡风险非劣效。
要点
- ASA≥3级患者同日出院全髋置换的急诊、再入院和并发症风险非劣于住院。
- ASA≥3级患者同日出院全膝置换的急诊、再入院、并发症和死亡风险均非劣于住院。
- 同日出院全髋置换的死亡风险非劣效性未获证实。
核心结论
- 高危患者同日出院全关节置换未增加急诊就诊、非计划再入院和并发症风险,提示可在医院环境下扩大同日出院指征并维持安全性。
研究设计与样本
- 基于Kaiser Permanente全关节置换登记系统的队列研究,纳入2017至2018年ASA分级≥3级、因骨关节炎行初次择期全关节置换的患者。
- 共纳入5250例全髋置换和9752例全膝置换患者,其中同日出院分别为1742例(33.2%)和3283例(33.7%)。
- 采用倾向评分加权Cox比例风险回归评估90天不良事件风险,并进行非劣效检验,界值为1.10。
主要发现
- 同日出院全髋置换 vs 住院:急诊就诊HR 0.73(单侧95%上限0.84),再入院HR 0.47(95%上限0.61),并发症HR 0.63(95%上限0.75),均非劣效;死亡HR 0.84(95%上限1.97),非劣效性证据不足。
- 同日出院全膝置换 vs 住院:急诊就诊HR 0.79(95%上限0.87),再入院HR 0.80(95%上限0.95),并发症HR 0.72(95%上限0.82),死亡HR 0.53(95%上限1.03),均非劣效。
关键数值与推荐
- 非劣效界值为1.10。
- 全髋置换同日出院急诊就诊HR 0.73(单侧95%上限0.84)、再入院HR 0.47(95%上限0.61)、并发症HR 0.63(95%上限0.75)、死亡HR 0.84(95%上限1.97)。
- 全膝置换同日出院急诊就诊HR 0.79(95%上限0.87)、再入院HR 0.80(95%上限0.95)、并发症HR 0.72(95%上限0.82)、死亡HR 0.53(95%上限1.03)。
临床怎么用
- 对于ASA分级≥3级的骨关节炎患者,同日出院全关节置换未增加90天急诊、再入院和并发症风险,可考虑在医疗机构内扩大同日出院指征。
- 全髋置换同日出院患者死亡风险的非劣效性未获证实,临床决策时需结合个体情况谨慎评估。
局限性
- 研究为观察性队列设计,虽采用倾向评分加权,仍可能存在未测量混杂。
- 结果基于特定登记系统人群,外推至其他医疗环境需谨慎。
- 死亡事件较少,全髋置换死亡风险非劣效性检验效能不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although safety in same-day discharge total joint arthroplasty (TJA) has been reported, findings are limited to healthier patients, specific surgeons, and/or specific institutions. Indications for same-day discharge TJA have expanded to include patients with multiple comorbidities; however, safety in this specific patient population remains unknown. Therefore, we sought to compare the risk of 90-day adverse events in higher-risk patients undergoing same-day discharge versus inpatient TJA. METHODS: The Kaiser Permanente Total Joint Replacement Registry was utilized to conduct a cohort study. All patients with an American Society of Anesthesiologists (ASA) classification of ≥3 who underwent primary elective TJA for osteoarthritis from 2017 through 2018 were identified. The risk of 90-day adverse events (i.e., emergency department visits, unplanned readmissions, complications, and mortality) was evaluated with use of propensity score-weighted Cox proportional hazard regression including noninferiority testing with a margin of 1.10. RESULTS: The cohort included a total of 5,250 patients who underwent total hip arthroplasty and 9,752 patients who underwent total knee arthroplasty, of whom 1,742 (33.2%) and 3,283 (33.7%) had same-day discharge, respectively. Same-day discharge hip arthroplasty was noninferior to an inpatient stay in terms of emergency department visits (hazard ratio [HR], 0.73; 1-sided HR 95% upper bound [UB], 0.84), readmissions (HR, 0.47; 95% UB, 0.61), and complications (HR, 0.63; 95% UB, 0.75); we did not have evidence of noninferiority for mortality (HR, 0.84; 95% UB, 1.97). Same-day discharge knee arthroplasty was noninferior to an inpatient stay in terms of emergency department visits (HR, 0.79; 95% UB, 0.87), readmission (HR, 0.80; 95% UB, 0.95), complications (HR, 0.72; 95% UB, 0.82), and mortality (HR, 0.53; 95% UB, 1.03). CONCLUSIONS: We found that same-day discharge TJA did not increase the risk of emergency department visits, unplanned readmissions, and complications compared with an inpatient stay for higher-risk patients, suggesting that it is possible to expand indications for same-day discharge TJA in the hospital setting while maintaining safety. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Reddy NC, Prentice HA, Paxton EW, et al. Association Between Same-Day Discharge Total Joint Arthroplasty and Risk of 90-Day Adverse Events in Patients with ASA Classification of ≥3. J Bone Joint Surg Am. 2021. PMID: 34495903. doi:10.2106/JBJS.20.02110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。